pulmonx.comPulmonx | Improving Breathing and Quality of Life for Emphysema Patients

English Deutsch Español Français Italiano Svenska Visit Patient Site United States United Kingdom Germany Technology Clinical Evidence Patient Selection Resources Clinical Education Treatment Centers Reimbursement Physician Training Clinical Spotlights Office Resources StratX CT Parameters About About Pulmonx Pulmonx History Pulmonx Management Team Careers Investors English Deutsch Español Français Italiano Svenska Helping Patients Breathe Easier, Do More & Enjoy Life Breakthrough Technology for Severe Emphysema The Zephyr Valve delivers durable clinical benefits – without surgery and its associated risks. 1-5 Patients experience: 1-5 Improved health status Improved lung function Increased exercise capacity Reduced breathlessness or dyspnea Reduced gas trapping Improved quality of life GOLD’s evidence A” rating affirms that endobronchial valves, like the Zephyr ® Valve, are a viable, minimally–invasive treatment option for severe emphysema, a form of COPD. 10 How It Works See how the Zephyr Valve treatment is performed as a minimally invasive lung volume reduction procedure to reduce hyperinflation and gas trapping in patients with severe emphysema. The Zephyr Valve is the first endobronchial valve to receive approval from the FDA for patients with either heterogenous and homogeneous emphysema. Learn More Selecting the Right Patient Assess with Certainty. Treat with Confidence. Pulmonx provides a comprehensive solution for identifying eligible patients, using tools to help physicians precisely identify: Patients most likely to benefit from Zephyr Valve treatment Target lobes for treatment, which could include upper and/or lower lobes Learn More Durable Clinical Benefits for Patients 1-5 Clinically-proven, safe and effective treatment for patients with severe emphysema Consistent clinical findings across four randomized control trials Learn More FEV 1 Change from Baseline 1 LIBERATE - FEV1 - Percent Change - Gray Background | amCharts *Intent to Treat 6MWD Change from Baseline 1 LIBERATE - 6MWD - Change from Baseline - Gray | amCharts SGRQ Change from Baseline 1 LIBERATE - SGRQ - Change from Baseline - Gray | amCharts Patient Benefits & Risks Patients treated with the Zephyr Valve compared to patients on medication alone were able to: 1 Return to activities that were previously limited Feel less shortness of breath Walk longer distances Have more energy Feel more confident leaving their home Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death. Randy Ayers Virginia Able to ride her horse without oxygen for the first time in years. Read More Greg’s Story Age at Treatment: 64 Morrisville, Indiana Unfortunately, my sister, who first told me about the valves, passed away from the disease so it is important for me to share my story to let others know about this treatment option before it’s too late. Read More Jeffrey’s Story Age at Treatment: 61 Concord, North Carolina I had immediate relief and felt like I was a 40-year-old again. I’m enjoying things I haven’t been able to enjoy in a while. I would recommend the procedure for anyone who qualifies! Read More Gary’s Story Age at Treatment: 72 Monroe, Louisiana These valves certainly changed my life for the better and I just want to help spread the word so others can have hope too. Read More View All Need more? Treatment Centers Connect With Us©2018-present Pulmonx Corporation or its affiliates. All rights reserved. All trademarks herein are the property of Pulmonx Corporation or its affiliates. US-EN-1401-v2 Resources About Pulmonx Management Team Company History For US Patients For Physicians Careers Contact Us Privacy Policy EU and UK Privacy Policy Terms of Use Terms and Conditions of Sale (U.S.) Sitemap Important Safety Information Follow Us Valve Zephyr. Class IIb. CE 2797. In order to provide you with an optimal website experience, we use cookies. By clicking "Accept" you agree to the use of cookies. Further information can be found in our privacy policy . Accept Privacy & Cookies Policy Close Privacy Overview This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on . Necessary Necessary Always Enabled Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information. Non-necessary Non-necessary Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website. SAVE & ACCEPT Disclaimer This information is intended for the use of HealthCare Professionals only. To access this information, please confirm you are a healthcare professional. Confirm as a Healthcare Professional I am not a Healthcare Professional X Disclaimer This information is intended for the use of HealthCare Professionals only. To access this information, please confirm you are a healthcare professional. If you are a Patient with COPD or have a loved one with COPD, please visit our dedicated website. Continue as a Healthcare Professional Continue as a Patient X こちらのウェブサイトは海外のサイトで医療従事者を対象としたものです。一般の方に対する情報提供を目的としたものではございません。当治療に関する情報を希望される場合は、かかりつけ医までお問合せください。 医療従事者のみなさま：当治療に関する情報提供を希望される場合、以下のお問合せフォームにてお知らせください。弊社の担当者から連絡させていただきます。 お名前 * 名 (First) 姓 (Last) ご施設 * Email * *この項目は入力必須です。 GLO-JP-1660-v1 X こちらのウェブサイトは海外のサイトで医療従事者を対象としたものです。一般の方に対する情報提供を目的としたものではございません。当治療に関する情報を希望される場合は、かかりつけ医までお問合せください。 医療従事者のみなさま：当治療に関する情報提供を希望される場合、以下のお問合せフォームにてお知らせください。弊社の担当者から連絡させていただきます。 お名前 * 名 (First) 姓 (Last) ご施設 * Email * *この項目は入力必須です。 GLO-JP-1660-v1 X You are visiting the Pulmonx global website. It is not for use by patients in Australia. To access the Australian Pulmonx website and Treatment Centre list, please visit Pulmonx.com.au Dismiss X Patient Eligibility Calculator...